Latest headlines from around the world.
7 Indian firms in race, experts eye cheaper Keytruda version in 2 years
Stock markets gain 1.6%, Nifty 50 above 24,000 pts on West Asia peace talk hopes
53 million tonnes output, 33% margins, 10x earnings: NMDC’s volume-price paradox
To lower cost burden, oncologists suggest smaller doses, but Keytruda says no
Painful paperwork, Rs 10 lakh upfront: India’s cancer patients locked out of best-selling drug
Merck & CO on Keytruda leak: ‘Healthcare facilities responsible for used packaging’
Rs 1.5 lakh a shot, ‘magic’ cancer drug leaked from top hospitals, fakes sold to desperate patients
Markets gain 6% over the week, snap six week losing streak
Equity mutual fund inflows hit 8-month high in March
